Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin.

Saved in:
Bibliographic Details
Title: Survival Impact of Adjuvant Nivolumab Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy with Docetaxel Plus 5-Fluorouracil and Cisplatin.
Authors: Sugase T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Kanemura T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Matsuura N; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Takeoka T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Ushimaru Y; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Masuike Y; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yanagimoto Y; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yamamoto K; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Omori T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Mori R; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Kitakaze M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Kubo M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Mukai Y; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Komatsu H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Sueda T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Kagawa Y; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Wada H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Yasui M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Miyata H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan. hiroshi.miyata@oici.jp.
Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Aug; Vol. 32 (8), pp. 5887-5897. Date of Electronic Publication: 2025 May 01.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1534-4681
DOI:10.1245/s10434-025-17332-7